ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS

This study has been completed.
Information provided by NIH AIDS Clinical Trials Information Service
Please refer to this study by its ClinicalTrials.gov identifier: NCT00002116


Locations
United States, California
Mount Zion Med Ctr / UCSF    
      San Francisco, California, United States, 94115
UCSF - San Francisco Gen Hosp    
      San Francisco, California, United States, 94110
Los Angeles County - USC Med Ctr    
      Los Angeles, California, United States, 90033
United States, Illinois
Rush Presbyterian - Saint Luke's Med Ctr    
      Chicago, Illinois, United States, 60612
United States, Maryland
Johns Hopkins Hosp    
      Baltimore, Maryland, United States, 21205
United States, North Carolina
Univ of North Carolina Hosps    
      Chapel Hill, North Carolina, United States, 27599
United States, Texas
Park Plaza Hosp    
      Houston, Texas, United States, 77004
United States, Washington
Univ of Washington / Viral Disease Clinic    
      Seattle, Washington, United States, 98122
Canada, British Columbia
Univ of British Columbia / Univ Hosp    
      Vancouver, British Columbia, Canada

Sponsors and Collaborators
Gilead Sciences





Links to all studies - primarily for crawlers